Browse > Article
http://dx.doi.org/10.6114/jkood.2018.31.1.071

A Clinical Study of 148 Patients with Soyangin Vitiligo  

Hong, Yo-Han (Haneulmaeum Oriental Medicine Clinic)
Kim, Sung-Won (Haneulmaeum Oriental Medicine Clinic)
Publication Information
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology / v.31, no.1, 2018 , pp. 71-80 More about this Journal
Abstract
Objectives : The purpose of this study is to evaluate the clinical aspects of patients with Soyangin vitiligo. Methods : This clinical investigation was made with 148 Soyangin Vitiligo patients who visited Haneulmaeum Oriental Medicine Clinic (Incheon) from July 1st 2007 to June 30th 2017. Results & Conclusions : 1. There were 73 males(49.3%) and 75 females(50.7%). 2. The Mean age at the first visit was 36.1 years(male: 36.4, female: 35.8). 3. The Mean age of onset was 27.9 years(male: 28.6, female: 27.4). 4. The mean duration of the disease was 8.0 years(male: 7.8, female: 8.3). 5. Of the 148 patients, 41(27.7%) had the symmetric lesions and 107(72.3%) had the asymmetric vitiligo lesions. Of the patients with asymmetric vitiligo lesions, 46(31.1%) had the localized lesions and 26(17.6%) had the segmental lesions and 35(24.3%) had the multiple lesions. 6. The most common site of initial involvement of the vitiligo was the face (39.2%). 7. The most common site of the vitiligo lesions was the face(49.3%). 8. Familial history was obtained in 12 patients(8.1%). 9. There was no known precipitating factor in most cases(89.4%). 10. Thyroid disease was the most common associated disease. 11. The progression of vitiligo was present in 92 patients(62.2%).
Keywords
Vitiligo; Soyangin; Clinical study;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ortonne JP, Mosher DB, Fitzpatrick TB. Hypomelanotic disorders: vitiligo and other hypomelanoses fo hair and skin. 6th ed. New York:Plenum. 1983:120-310.
2 Lerner AB. Vitilgo. J Invest Dermatol. 1959;32:285-310.   DOI
3 Masher DB, Fitzpatrick TB, Ortonne JP. Abnormalities of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in General Medicine. 2nd ed. New York:McGraw-Hill Book. 1979:582-90.
4 Betterie C, Caretto A, De Zio A, Pedini B, Velle-Fornasa. Incidence and significance of organ-specific autoimmune disorder in patients with vitiligo. Dermatologica. 1985;171:419-23.   DOI
5 Koga M. Vitiligo: a new classification and therapy. Br J Dermatol. 1977;97:255-61.   DOI
6 Lerner AB. On the etiology of vitiligo and gray hair. Am J Med. 1971;51:147-56.
7 Karin US, Mark RP, John MW. Free fadical reduction by Thioredoxin reductase at the surface of normal and vitiliginous haman keratinocytes. J Invest Dermatol. 1986;87:728-32.   DOI
8 Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly AP, Alfred L. T cell profiles in vitiligo. J Am Acad Dermatol. 1986;14:196-201.   DOI
9 Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanoses and hypermelanoses. In: Freedberg IM, Eisen AZ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill Book. 1999;945-1017.
10 Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol. 2000;17:189-93.   DOI
11 Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis. 2007;79:277-80.
12 Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol. 1988;118:223-8.   DOI
13 Jeon EK, Park YO, Kim CD, Seo YJ, Lee JH, Park JK. The clinical significance of symmetry in the distribution of vitiligo lesions. Korean J Dermatol. 2008;46:40-5.
14 Jeon EK, Park YO, Seo YJ, Lee JH, Park JK. Assessment of the Quality of Life in Vitiligo Patients. Korean J Dermatol. 2008;46:74-80.
15 Hong SY, Yie UH. Principles of Sasang Medicine. Seoul:Haenglim. 1994:134-6, 275-8,301,325-6.
16 Ji SY, Kwon YK, Shin SK. The study on the oriental and western Medical literatures of vitiligo. J of Jaehan Oriental Medical academy. 1999;4(1):262-85.
17 Park SR, Yun JI, Lim SD. Clinical study of 217 cases of vitiligo. Korean J Dermatol. 1981;19:171-82.
18 Park KC, Youn JI, Lee YS. Clinical study of 326 cases of vitiligo. Korean J Dermatol. 1988;26:200-5.
19 Yu HJ, Park KC, Ahn JS. Clinical study of vitiligo. Korean J Dermatol. 1998;36:1037-42.
20 Levai M. A study of certain contributory factors in the development of vitiligo in South Indian patients. Arch Dermatol. 1958;78:364-71.   DOI
21 Kim YC, Kin W, Hann SK. The genetics of vitiligo in Korean patients. Korean J Dermatol. 1996;34:968-72.
22 Halder RM, Taliaferro SJ. Vitiligo. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York:McGraw-Hill. 2008:616-22.
23 Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA Jr. Childhood vitiligo. J Am Acad Dermatol. 1987;16:948-54.   DOI
24 Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-66.   DOI
25 Cunliffe WJ, Hall R, Newell DJ, et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135-9.   DOI
26 Kim TH. The recent therapeutics of vitiligo. Korean J Dermatol. 2007;59:113.